Panacea Bio receives license from DCGI to produce Sputnik V vaccine
Panacea Biotec, in a release on Sunday, announced that it has received a licence from the DCGI for manufacturing the Sputnik V vaccine in its Himachal Pradesh facility.
Jul 05, 2021, 14:09 PM IST
COVID-19: Hetero gets DCGI nod to launch anti-viral drug remdesivir
The company has received the manufacturing and marketing approval for Remdesivir from the Drug Controller General of India (DCGI) for the treatment of COVID-19, it said in a statement.
Jun 21, 2020, 14:38 PM IST
